Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR

Carregando...
Imagem de Miniatura
Citações na Scopus
52
Tipo de produção
article
Data de publicação
2017
Editora
SPRINGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
CATALANO, Onofrio A.
SAHANI, Dushyant V.
VANGEL, Mark G.
GEE, Michael S.
HAHN, Peter F.
WITZEL, Thomas
SORICELLI, Andrea
SALVATORE, Marco
CATANA, Ciprian
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
ABDOMINAL RADIOLOGY, v.42, n.4, Special Issue, p.1141-1151, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Purpose: Correct staging is imperative for colorectal cancer (CRC) since it influences both prognosis and management. Several imaging methods are used for this purpose, with variable performance. Positron emission tomography-magnetic resonance (PET/MR) is an innovative imaging technique recently employed for clinical application. The present study was undertaken to compare the staging accuracy of whole-body positron emission tomography-computed tomography (PET/CT) with whole-body PET/MR in patients with both newly diagnosed and treated colorectal cancer. Methods: Twenty-six patients, who underwent same day whole-body (WB) PET/CT and WB-PET/MR, were evaluated. PET/CT and PET/MR studies were interpreted by consensus by a radiologist and a nuclear medicine physician. Correlations with prior imaging and follow-up studies were used as the reference standard. Correct staging was compared between methods using McNemar's Chi square test. Results: The two methods were in agreement and correct for 18/26 (69%) patients, and in agreement and incorrect for one patient (3.8%). PET/MR and PET/CT stages for the remaining 7/26 patients (27%) were discordant, with PET/MR staging being correct in all seven cases. PET/MR significantly outperformed PET/CT overall for accurate staging (P = 0.02). Conclusion: PET/MR outperformed PET/CT in CRC staging. PET/MR might allow accurate local and distant staging of CRC patients during both at the time of diagnosis and during follow-up.
Palavras-chave
PET/MR, Colorectal cancer, Staging, PET/CT, Whole-body staging
Referências
  1. Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
  2. Al-Nabhani KZ, 2014, J NUCL MED, V55, P88, DOI 10.2967/jnumed.113.123547
  3. American College of Radiology, 2016, ACR APPR CRIT
  4. Antoch G, 2003, JAMA-J AM MED ASSOC, V290, P3199, DOI 10.1001/jama.290.24.3199
  5. Bipat S, 2004, RADIOLOGY, V232, P773, DOI 10.1148/radiol.2323031368
  6. Boss A, 2010, J NUCL MED, V51, P1198, DOI 10.2967/jnumed.110.074773
  7. Brendle C, 2016, EUR J NUCL MED MOL I, V43, P123, DOI 10.1007/s00259-015-3137-z
  8. Brush B, 2011, HEALTH TECHNOL ASSES, DOI [10.3310/hta15350, DOI 10.3310/HTA15350]
  9. Catalano OA, 2013, RADIOLOGY, V269, P857, DOI 10.1148/radiol.13131306
  10. Chandarana H, 2013, RADIOLOGY, V268, P874, DOI 10.1148/radiol.13130620
  11. Chen YM, 2008, NUCL MED COMMUN, V29, P425, DOI 10.1097/MNM.0b013e3282f4d389
  12. Cheng G, 2013, EUR J NUCL MED MOL I, V40, P779, DOI 10.1007/s00259-013-2343-9
  13. Cohade C, 2003, J NUCL MED, V44, P1797
  14. Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726
  15. Even-Sapir E, 2004, RADIOLOGY, V232, P815, DOI 10.1148/radiol.2323031065
  16. Fletcher JW, 2008, J NUCL MED, V49, P480, DOI 10.2967/jnumed.107.047787
  17. Hany TF, 2002, RADIOLOGY, V225, P575, DOI 10.1148/radiol.2252011568
  18. Haug U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088407
  19. Howlander N, 2014, SEER CANC STAT REV
  20. Kanas Gena P, 2012, Clin Epidemiol, V4, P283, DOI 10.2147/CLEP.S34285
  21. Kang B, 2016, AM J ROENTGENOL, V206, pW10, DOI 10.2214/AJR.14.13818
  22. Kinkel K, 2002, RADIOLOGY, V224, P748, DOI 10.1148/radiol.2243011362
  23. Kong G, 2008, EUR J NUCL MED MOL I, V35, P1323, DOI 10.1007/s00259-008-0743-z
  24. Kwok H, 2000, INT J COLORECTAL DIS, V15, P9, DOI 10.1007/s003840050002
  25. Laffon E, 2009, NUCL MED COMMUN, V30, P455, DOI 10.1097/MNM.0b013e32832bdcac
  26. Lee SJ, 2015, CLIN NUCL MED, V40, pE392, DOI 10.1097/RLU.0000000000000812
  27. Low RN, 2003, ABDOM IMAGING, V28, P784, DOI 10.1007/s00261-003-0032-z
  28. Michielsen K, 2014, EUR RADIOL, V24, P889, DOI 10.1007/s00330-013-3083-8
  29. Nagtegaal ID, 2008, J CLIN ONCOL, V26, P303, DOI 10.1200/JCO.2007.12.7027
  30. Nie YK, 2006, J NUCL MED, V47, P1075
  31. Niekel MC, 2010, RADIOLOGY, V257, P674, DOI 10.1148/radiol.10100729
  32. Paspulati RM, 2015, ABDOM IMAGING, V40, P1415, DOI 10.1007/s00261-015-0474-0
  33. Rappeport ED, 2007, ACTA RADIOL, V48, P369, DOI 10.1080/02841850701294560
  34. Schulthess G, 2009, EUROPEAN J NUCL M S1, V36, P3, DOI 10.1007/S00259-008-0940-9
  35. Sobin LH, 2010, TNM CLASSIFICATION M
  36. U. S. Cancer Working Group, 2015, US CANC STAT 1999 20
  37. Veil-Haibach P, 2006, JAMA-J AM MED ASSOC, V296, P2590